By Gilles Guillaume and Nick Carey (Reuters) -French automaker Renault on Wednesday reported a slightly lower than expected full-year 2023 net profit, but posted margin and revenue gains and offered more cash to investors with a huge increase in its…
OTTAWA (Reuters) - Bank of Canada (BoC) Deputy Governor Toni Gravelle will discuss normalization of the central bank's balance sheet in a speech on March 21, the CFA Society of Toronto said in a post on its website. There's been…
By Samrhitha A (Reuters) -Uber Technologies shot to a record high on Wednesday after announcing its first-ever buyback of $7 billion worth of company shares after a strong recovery in ride-share revenue and healthy demand in its food delivery business.…
By Shivansh Tiwary and Rajesh Kumar Singh (Reuters) -Shares of JetBlue Airways surged on Tuesday after activist investor Carl Icahn said he took a stake of nearly 10% in the low-cost carrier. JetBlue's shares were up 14.7% in late morning…
MEXICO CITY (Reuters) -Mexican antitrust regulator Cofece said on Tuesday it had identified "possible barriers" to competition in the e-commerce market, with Amazon and Mercado Libre together controlling more than 85% of transactions and sales. In a preliminary report shared…
By Marisa Taylor WASHINGTON (Reuters) - U.S. worker safety officials fined Elon Musk’s SpaceX $3,600 this month after an accident at its site in Washington state led to a “near amputation,” according to inspection records reviewed by Reuters. A Reuters…
By Valerie Insinna WASHINGTON (Reuters) - Boeing said on Tuesday it delivered 27 airplanes in January, which was down 29% from the same month last year as regulators, lawmakers and customers pressured the planemaker following a MAX 9 mid-air cabin…
By Deborah Mary Sophia (Reuters) -Restaurant Brands International beat Wall Street estimates for quarterly results on Tuesday, fueled by early success of an ongoing turnaround at its Burger King business and robust demand at coffee chain Tim Hortons. The company's…
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product revenue as top-selling drugs face tough competition and sales of newer treatments take off slowly, but said there are signs its new Alzheimer's drug is gaining…
A look at the day ahead in U.S. and global markets from Mike Dolan Frenetic trading activity around artificial intelligence and chipmakers has tech heavy stock indexes from Wall St's Nasdaq to Japan's Nikkei just a stone's throw from all-time…
